Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: Measurements with stable isotopes

Kidney International

Volumn 53, Issue 1, 1998, Pages 181-188

  De Sain Van Der Velden, Monique G M ^a   Kaysen, George A ^b   De Meer, Kees ^b   Stellaard, Frans ^b   Voorbij, Hieronymus A M ^b   Reijngoud, Dirk Jan ^b   Rabelink, Ton J ^b   Koomans, Hein A ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Albumin; Fibrinogen; Isotope measurement; Nephrotic syndrome

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; CARBON 13; FIBRINOGEN; SERUM AMYLOID A; VALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; ISOTOPE LABELING; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0031951669     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00729.x     Document Type: Article

References (68)

1. KAYSEN GA: Plasma composition in the nephrotic syndrome. Am J Nephrol 13:347-359, 1993
2. WHEELER DC, BERNARD DB: Lipid abnormalities in the nephrotic syndrome: Causes, consequences, and treatment. Am J Kidney Dis 23:331-346, 1994
3. KEANE WF, KASISKE BL: Hyperlipidemia in the nephrotic syndrome. N Engl J Med 323:603-604, 1990
4. D'AMICO G: Lipid changes in the nephrotic syndrome: New insights into pathomechanisms and treatment. Klin Wochenschr 69:618-622, 1991
5. FAUCHER C, DOUCET C, BAUMELOU A, CHAPMAN J, JACOBS C, THILLET J: Elevated lipoprotein (a) levels in primary nephrotic syndrome. Am J Kidney Dis 22:808-813, 1993
6. JOVEN J, SIMO JM, VILELLA E, CAMPS J, ESPINEL E, VILLABONA C: Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: Relation to remission of proteinuria. Clin Chem 41:908-913, 1995
7. OHTA T, MATSUDA I: Lipid and apolipoprotein levels in patients with nephrotic syndrome. Clin Chim Acta 117:133-143, 1981
8. SUN X, MARTIN V, WEISS RH, KAYSEN GA: Selective transcriptional augmentation of hepatic gene expression in the rat with Heymann nephritis. Am J Physiol 264:F441-F447, 1993
9. VAZIRI ND, GONZALES E, BARTON CH, CHEN HT, NGUYEN Q, ARQUILLA M: Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis. J Lab Clin Med 117:152-156, 1991
10. RYDZEWSKI A, MYSLIWIEC M, SOSZKA J: Concentration of three thrombin inhibitors in the nephrotic syndrome in adults. Nephron 42:200-203, 1986
11. GIROT R, JAUBERT F, LEON M, BELLON B, AIACH M, JOSSO F, LEPELLETIER O, BEGUIN S, MONNET JP: Albumin, fibrinogen, prothrombin and antithrombin III variations in blood, urines and liver in rat nephrotic syndrome (Heymann nephritis). Thromb Haemost 49: 13-17, 1983
12. KAYSEN GA, MYERS BD, COUSER WG, RABKIN R, FELTS JM: Mechanisms and consequences of proteinuria. Lab Invest 54:479-498, 1986
13. LEWANDOWSKI AE, LIAO WSL, STINSON-FISHER CA, KENT JD, JEFFERSON LS: Effects of experimentally induced nephrosis on protein synthesis in rat liver. Am J Physiol 254:C634-C642, 1988
14. KAYSEN GA, GAMBERTOGLIO J, JIMENEZ I, JONES H, HUTCHISON FN: Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int 29:572-577, 1986
15. KAYSEN GA, KIRKPATRICK WG, COUSER WG: Albumin homeostasis in the nephrotic rat: Nutritional considerations. Am J Physiol 247: F192-F202, 1984
16. KAYSEN GA, JONES H JR, MARTIN V, HUTCHISON FN: A low-protein diet restricts albumin synthesis in nephrotic rats. J Clin Invest 83:1623-1629, 1989
17. 13C]leucine. Kidney Int 41:132-138, 1992
18. MARSH JB: Lipoprotein metabolism in experimental nephrosis. J Lipid Res 25:1619-1623, 1984
19. AL-BANDER HA, MARTIN VI, KAYSEN GA: Plasma IgG pool is not defended from urinary loss in nephrotic syndrome. Am J Physiol 262:F333-F337, 1992
20. 131-labelled human serum albumin in man. J Clin Invest 32:138-148, 1953
21. KORNER A, DEBRO JR: Solubility of albumin in alcohol after precipitation by trichloric acid: A simplified procedure for seperation of albumin. Nature 4541:1067, 1956
22. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
23. VILA V, REGANON E, LLOPIS F, AZNAR J: A rapid method for isolation of fibrinogen from human plasma by precipitation with polyethylene glycol 6,000. Thromb Res 39:651-656, 1985
24. HILL RL: Hydrolysis of proteins. Advantages of Prot Chem 20:37-107, 1965
25. HUŠEK P: Rapid dervatization and gas chromatographic determination of amino acids. J Chromatogr 552:259-299, 1991
26. YARASHESKI KE, SMITH K, RENNIE MJ, BIER DM: Measurement of muscle protein fractional synthetic rate by capillary gas chromatography/combustion isotope ratio mass spectrometry. Biol Mass Spectrom 21:486-490, 1992
27. VON CLAUSS A: Rapid physiological coagulation method in determination of fibrinogen. Acta Heamatol 17:237-246, 1957
28. COBELLI C, TOFFOLO G, FOSTER DM: Tracer-to-tracee ratio for analysis of stable isotope tracer data: Link with radioactive kinetic formalism. Am J Physiol 262:E968-E975, 1992
29. FOSTER DM, BARRETT PH, TOFFOLO G, BELTZ WF, COBELLI C: Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data. J Lipid Res 34:2193-2205, 1993
30. PARHOFER KG, HUGH P, BARRETT R, BIER DM, SCHONFELD G: Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes. J Lipid Res 32:1311-1323, 1991
31. TAKEDA Y, CHEN AY: Fibrinogen metabolism and distribution in patients with the nephrotic syndrome. J Lab Clin Med 70:678-685, 1967
32. JENSEN H, ROSSING N, ANDERSON SB, JARNUM S: Albumin metabolism in the nephrotic syndrome in adults. Clin Sci 33:445-457, 1967
33. RENNIE MJ, SMITH K, WATT PW: Measurement of human tissue protein synthesis: An optimal approach. Am J Physiol 266:E298-E307, 1994
34. DE FEO P, HORBER FF, HAYMOND MW: Meal stimulation of albumin synthesis: A significant contributor to whole body protein synthesis in humans. Am J Physiol 263:E794-E799, 1992
35. DE FEO P, GAISANO MG, HAYMOND MW: Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest 88:833-840, 1991
36. CAYOL M, TAUVERON I, RAMBOURDIN F, PRUGNAUD J, GACHON P, THIEBLOT P, GRIZARD J, OBLED C: Whole-body protein turnover and hepatic protein synthesis are increased by vaccination in man. Clin Sci 89:389-396, 1995
37. BALLMER PE, MCNURLAN MA, MILNE E, HEYS SD, BUCHAN V, CALDER AG, GARLICK PJ: Measurement of albumin synthesis in humans: A new approach employing stable isotopes. Am J Physiol 259:E797-E803, 1990
38. BALLMER PE, WALSHE D, MCNURLAN MA, WATSON H, BRUNT PW, GARLICK PJ: Albumin synthesis rates in cirrhosis: Correlation with Child-Turcotte classification. Hepatology 18:292-297, 1993
39. SMITH K, DOWNIE S, BARUA JM, WATT PW, SCRIMGEOUR CM, RENNIE MJ: Effect of a flooding dose of leucine in stimulating incorporation of constantly infused valine into albumin. Am J Physiol 266:E640-E644, 1994
40. ZACHWIEJA JJ, BIER DM, YARASHESKI KE: Growth hormone administration in older adults: Effects on albumin synthesis. Am J Physiol 266:E840-E844, 1994
41. BALLMER PE, MCNURLAN MA, HULTER HN, ANDERSON SE, GARLICK PJ, KRAPF R: Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 95:39-45, 1995
42. HUNTER KA, BALLMER PE, ANDERSON SE, BROOM J, GARLICK PJ, MCNURLAN MA: Acute stimulation of albumin synthesis rate with oral meal feeding in healthy subjects measured with [ring-H-2(5)] phenylalanine. Clin Sci 88:235-242, 1995
43. 5ring]phenylalanine are not responsive to short-term intravenous nutrients in healthy humans. J Nutr 125:512-519, 1995
44. HALLIDAY D, VENKATESAN S, PACY P: Apolipoprotein metabolism: A stable-isotope approach. Am J Clin Nutr 57(Suppl):S726-S730, 1993
45. ZAHRINGER J, BALIGA BS, MUNRO HN: Increased levels of microsomal albumin-mRNA in the liver of nephrotic rats. FEBS Lett 62:322-325, 1976
46. MAURICE M, FELDMANN G, DRUET P, LALIBERTE F, BOUIGE D: Immunoperoxidase localization of albumin in hepatocytes of nephrotic rats with special reference to changes in the Golgi apparatus. Lab Invest 40:39-45, 1979
47. SUN X, KAYSEN GA: Albumin and transferrin synthesis are increased in H4 cells by serum from analbuminemic or nephrotic rats. Kidney Int 45:1381-1387, 1994
48. KAYSEN GA: Albumin metabolism in the nephrotic syndrome: The effect of dietary protein intake. Am J Kidney Dis 12:461-480, 1988
49. KAYSEN GA, GAMBERTOGLIO J, FELTS J, HUTCHINSON FN: Albumin synthesis, albuminuria and hyperlipemia in nephrotic patients. Kidney Int 31:1368-1376, 1987
50. BAUSSERMAN LL, HERBERT PN, MCADAM KPWJ: Heterogeneity of human serum amyloid A proteins. J Exp Med 152:641-656, 1980
51. JÜNGST D, CASELMANN WH, KUTSCHERA P, WEISWEILER P: Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome. Clin Chim Acta 168:159-167, 1987
52. SHORE VG, FORTE T, LICHT H, LEWIS SB: Serum and urinary lipoproteins in the human nephrotic syndrome: Evidence for renal catabolism of lipoproteins. Metabolism 31:258-268, 1982
53. 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum 20:129-147, 1990
54. GERSOVITZ M, MUNRO HN, UDALL J, YOUNG VR: Albumin synthesis in young and elderly subjects using a new stable isotope methodology: Response to level of protein intake. Metabolism 29:1075-1086, 1980
55. BALLEISEN L, BAILEY J, EPPING PH, SCHULTE H, VAN DE LOO J: Epidemiologieal study on factor VII, factor VIII and fibrinogen in an industrial population. I. Baseline data on the relation to age, gender, body weight, smoking, alcohol, pill-using, and menopause. Thromb Heamostas 54:475-479, 1985
56. AILLAUD MF, PIGNOL F, ALESSI MC, HARLE JR, ESCANDE M, MONGIN M, JUHAN-VAGUE I: Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age. Thromb Haemost 55:330-332, 1986
57. WILHELMSEN L, SVARDSUDD K, KORSAN BENGTSEN K, LARSSON B, WELIN L, TIBBLIN G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311:501-505, 1984
58. HANDA K, KONO S, SAKU K, SASAKI J, KAWANO T, SASAKI Y, HIROKI T, ARAKAWA K: Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. Atherosclerosis 77:209-213, 1989
59. LEVENSON J, GIRAL P, RAZAVIAN M, GARIEPY J, SIMON A: Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler Thromb Vasc Biol 15:1263-1268, 1995
60. SHARP DS, ABBOTT RD, BURCHFIEL CM, RODRIGUEZ BL, TRACY RP, YANO K, CURB JD: Plasma fibrinogen and coronary heart disease in elderly Japanese-American men. Arterioscler Thromb Vasc Biol 16: 262-268, 1996
61. YARNELL JW, BAKER IA, SWEETNAM PM, BAINTON D, O'BRIEN JR, WHITEHEAD PJ, ELWOOD PC: Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 83:836-844, 1991
62. BENDERLY M, GRAFF E, REICHLER-REISS H, BEHAR S, BRUNNER D, GOLDBOURT U: Fibrinogen is a predictor of mortality in coronary heart disease patients. Arterioscler Thromb Vasc Biol 16:351-356, 1996
63. KENDALL AG, LOHMANN RC, DOSSETOR JB: Nephrotic syndrome. A hypercoagulable state. Arch Intern Med 127:1021-1027, 1971
64. RABELINK TJ, ZWAGINGA JJ, KOOMANS HA, SIXMA JJ: Thrombosis and hemostasis in renal disease. Kidney Int 46:1-10, 1994
65. SAGRIPANTI A, BARSOTTI G: Hypercoagulability, intraglomerular coagulation, and thromboembolism in nephrotic syndrome. Nephron 70:271-281, 1995
66. ZWAGINGA JJ, KOOMANS HA, SIXMA JJ, RABELINK TJ: Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. J Clin Invest 93:204-211, 1994
67. ERNST E: Lowering the plasma fibrinogen concentration with drugs. Clin Pharm 11:968-971, 1992
68. GOERDT C, RUBINS HB, SWAIM W, FOLSOM A: Can phenytoin lower plasma fibrinogen concentrations? Thromb Res 79:231-236, 1995